Clinical Trials Logo
  1. Home
  2. Electrical Impedance Tomography
  3. NCT04245241
  4. Details
NCT04245241 Clinical Trial

Effects of High-Flow Nasal Cannula Therapy Assessed by Electrical Impedance Tomography

Electrical Impedance Tomography Clinical Trial

Official title:
Effects of High-Flow Nasal Cannula Therapy on Lung Recruitment and Lung Strain Change Assessed by Electrical Impedance Tomography

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04245241
Other study ID # EIT-HFNC
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 1, 2018
Est. completion date November 1, 2019

Study information
Verified date January 2020
Source Peking Union Medical College Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aimed to determine the effects of HFNC therapy on lung recruitment and lung strain change assessed by electrical impedance tomography (EIT)

Recruitment information / eligibility
Status Completed
Enrollment 24
Est. completion date November 1, 2019
Est. primary completion date July 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility - Inclusion Criteria:

- Patient who received a HENC therapy within 24 h after the extubation

Exclusion Criteria:

- Aged <18 years

- Pregnancy

- Body mass index (BMI) over 50 kg/m2

- ribcage malformation .any contraindication of using EIT monitoring (automatic implantable cardioverter defibrillator, chest skin injury, etc.).

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• High-flow nasal cannula (HFNC)
24 patients who receiving HFNC within 24 hours after extubation were prospectively enrolled in this study. EIT was used to monitor regional lung ventilation distributions at baseline (conventional oxygen therapy) and three flow rate levels of HFNC therapy (20, 40 and 60 L/min).

Locations
Country Name City State
China Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Beijing

Sponsors (1)
Lead Sponsor Collaborator
Peking Union Medical College Hospital

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary lung regional ventilation distribution lung regional ventilation distribution measured by EIT minute 80
See also
  Status Clinical Trial Phase
Recruiting NCT06375538 - Ultrasound Evaluations of Diaphragm and Intercostal Muscle to Predict the Failure of High-Flow Nasal Cannula Therapy
Completed NCT06146439 - The Factors Causing Treatment Failure in Children Receiving Oxygen Therapy With High-flow Nasal Cannula
Recruiting NCT05526534 - A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms N/A
Completed NCT04353531 - Investigate the Aerosol Particle Distribution During Aerosol Generating Procedures
Active, not recruiting NCT03928535 - Effect of Postextubation High-Flow Nasal Cannula vs Noninvasive Ventilation in Patients With Hypercapnic COPD N/A
Recruiting NCT05401474 - Individualization Flow in Patients Treated With High Flow Nasal Therapy (iFLOW) N/A
Recruiting NCT04481295 - Study on Optimal Oxygen Concentration During Pulmonary Rehabilitation N/A
Completed NCT04471220 - Exercise Capacity Under Various FiO2 and Oxygen Flow Rates Using HFNC N/A
Completed NCT04608331 - Dexmedetomidine Supplemented Analgesia in Patients at High-risk of Obstructive Sleep Apnea Phase 4
Recruiting NCT03449056 - High-flow Nasal Cannula Nebulization of Beta 2 Adrenergic Agonist During Acute Exacerbation of Chronic Obstructive Pulmonary Disease Phase 3
Recruiting NCT06425406 - Application of HFNC for Children N/A
Recruiting NCT04212182 - The Physiological Effect of High Flow Oxygen Therapy N/A
Recruiting NCT04184089 - High Flow Nasal Cannula in Patients Undergoing ERCP Retrograde Cholangiopancreatography With Intravenous Sedation. N/A